These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6130903)

  • 1. Effects of three recombinant human leukocyte interferons on drug metabolism in mice.
    Parkinson A; Lasker J; Kramer MJ; Huang MT; Thomas PE; Ryan DE; Reik LM; Norman RL; Levin W; Conney AH
    Drug Metab Dispos; 1982; 10(6):579-85. PubMed ID: 6130903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of acute and repeated chlordimeform treatment on rat hepatic microsomal drug metabolizing enzymes.
    Budris DM; Yim GK; Schnell RC
    J Environ Pathol Toxicol Oncol; 1984 Jul; 5(4-5):175-82. PubMed ID: 6440975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of p-amino-diphenyl ethers on hepatic microsomal cytochrome P450.
    Jiang H; Xuan G
    Pharmazie; 2003 Sep; 58(9):654-6. PubMed ID: 14531464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.
    Atal CK; Dubey RK; Singh J
    J Pharmacol Exp Ther; 1985 Jan; 232(1):258-62. PubMed ID: 3917507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in the activity of the drug-metabolizing enzymes of rat liver following the administration of tilorone hydrochloride.
    Leeson GA; Biedenbach SA; Chan KY; Gibson JP; Wright GJ
    Drug Metab Dispos; 1976; 4(3):232-8. PubMed ID: 6227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of tetrachlorophthalic anhydride on hepatic microsomal metabolism in rats and mice.
    Ridley WP; Warren J; Nair RS
    J Toxicol Environ Health; 1988; 24(2):217-27. PubMed ID: 3385798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression of the hepatic cytochrome P-450 monooxygenase system by treatment of mice with the antineoplastic agent 5-azacytidine.
    Gooderham NJ; Mannering GJ
    Cancer Res; 1985 Apr; 45(4):1569-72. PubMed ID: 2579731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of interferon on drug metabolism.
    Sonnenfeld G; Harned CL; Nerland DE
    Tex Rep Biol Med; 1981-1982; 41():363-9. PubMed ID: 6817439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of various purified interferons on effects of drugs in mice.
    Moore JA; Marafino BJ; Stebbing N
    Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):113-25. PubMed ID: 6189163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of hepatic cytochrome P450 modulation during Listeria monocytogenes infection in mice.
    Armstrong SG; Renton KW
    Mol Pharmacol; 1993 Apr; 43(4):542-7. PubMed ID: 8379989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
    Brunda MJ; Rosenbaum D
    Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of xanthine oxidase and heme oxygenase and depression of liver drug metabolism by interferon: a study with different recombinant interferons.
    Ghezzi P; Saccardo B; Bianchi M
    J Interferon Res; 1986 Jun; 6(3):251-6. PubMed ID: 3018103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heme enhances hexobarbital metabolism in perfused rat liver after drug-mediated destruction of cytochrome P-450.
    Farrell GC; Gollan JL; Correia MA; Schmid R
    J Pharmacol Exp Ther; 1981 Aug; 218(2):363-7. PubMed ID: 7252836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity.
    Edwards BS; Hawkins MJ; Borden EC
    Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):582-7. PubMed ID: 6149908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic exposure to cadmium on renal cytochrome P450-dependent monooxygenase system in rats.
    Plewka A; Plewka D; Nowaczyk G; Brzóska MM; Kamiński M; Moniuszko-Jakoniuk J
    Arch Toxicol; 2004 Apr; 78(4):194-200. PubMed ID: 14595535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.
    Griffeth LK; Rosen GM; Rauckman EJ
    Drug Metab Dispos; 1984; 12(5):588-95. PubMed ID: 6149909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxapram inhibits the in vitro oxidation of hexobarbital.
    Ishikawa M; Ozaki M; Takayanagi Y; Sasaki K
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):371-4. PubMed ID: 1719592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.